Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Griprest
- Development stage
- Unknown
- Lead developer
- Centaur Pharmaceuticals
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Griprest (also marketed as Griperest) is an oral pediatric drop formulation developed by Centaur Pharmaceuticals to support gastrointestinal health and alleviate symptoms of infantile colic, abdominal pain, and flatulence. It is a combination product containing the probiotic strain *Lactobacillus rhamnosus* GG (ATCC 53103) along with carminative dill oil and fennel seed oil. *Lactobacillus rhamnosus* GG helps restore and maintain a healthy balance of gut microbiota, improves epithelial barrier function, and supports immune homeostasis. The carminative dill and fennel oils act to relax gastrointestinal smooth muscle, reduce cramping, and facilitate the expulsion of gas, thereby relieving abdominal discomfort in infants.
- Brand names
- GriperestGriprest
- Other names
- Lactobacillus rhamnosus GG + dill oil + fennel oil
Beyond the preview
Go deeper on Griprest.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Griprest.